Independent Newspaper Nigeria on MSN: Chronic respiratory diseases, neglected global epidemic demands urgent action Chronic respiratory diseases (CRDs) account for more than four million deaths annually, ranking as the third leading cause of death worldwide. Despite this immense burden, CRDs remain largely absent ... The magnitude of chronic respiratory diseases (CRDs) across Europe has been overlooked, leading to under- and misdiagnosis, poor management, and inadequate funding, according to a new report.
News Medical: New insights into the link between respiratory infections and chronic lung diseases New insights into the link between respiratory infections and chronic lung diseases Yahoo Finance: Sanofi’s bispecific scores in respiratory diseases but fails in eczema Two of Sanofi’s lunsekimig Phase II trials have met their primary endpoints in respiratory disease, while a study in atopic dermatitis failed to show benefit. The drug showed benefit in ... Atlanta Journal-Constitution: Pope Francis battled chronic lung disease. Here’s what we know about it Pope Francis, history’s first pontiff from Latin America, has died.
chronic respiratory disease, The 88-year-old religious leader battled chronic lung disease throughout his life, ending in over a monthlong hospitalization for ... Pope Francis battled chronic lung disease. Here’s what we know about it Breathing is something you normally do without thinking. Adults do it some 12-18 times per minute. For your patients with chronic respiratory illness, every breath is not always so easy and automatic.
chronic respiratory disease, Reuters on MSN: AstraZeneca drug reduces flare-ups of chronic lung disease in late-stage trials By Pushkala Aripaka, Nithyashree R B and Maggie Fick March 27 (Reuters) - AstraZeneca's experimental drug tozorakimab reduced flare-ups of chronic obstructive pulmonary disease in two late-stage ...
